GGrantIndex
Sort

82,697 grants matching vaccine development

NIAID Preclinical Development Support - HIV-1 Envelope Protein Production

$5,140,196
Jon Carl Mirsalis · Advanced Bioscience Laboratories, Inc. · N01 · FY2013 · AI

Biodefense and Emerging Infectious Disease Vaccine Studies

$5,127,139
Julie E. Ledgerwood · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI

COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT

$5,126,908
Edward E Partridge · University Of Alabama At Birmingham · P30 · FY2016 · CA

Core B: System Biological Analyses of Innate and Adpative Responses to Vaccination

$5,125,237
Mark Joseph Mulligan · Emory University · U19 · FY2020 · AI

Project 3: Antigen design

$5,122,197
Neil King · University Of Washington · U19 · FY2024 · AI

Development of Nipah virus mRNA vaccine

$5,117,389
Rosemarie Mason · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI

HIV Monoclonal Antibody Studies

$5,113,889
Julie E. Ledgerwood · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI

COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT

$5,113,872
Michael Birrer · University Of Alabama At Birmingham · P30 · FY2017 · CA

HIV Monoclonal Antibody Studies

$5,109,113
Lesia Dropulic · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI

Center of Excellence for Encephalitic Alphavirus Therapeutics

$5,108,171
Colleen B Jonsson · University Of Tennessee Health Sci Ctr · U19 · FY2021 · AI

COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT

$5,103,202
Barry P Sleckman · University Of Alabama At Birmingham · P30 · FY2020 · CA

COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT

$5,103,202
Barry P Sleckman · University Of Alabama At Birmingham · P30 · FY2019 · CA

University of Washington Center for Aids Research

$5,099,975
King Kennard Holmes · University Of Washington · P30 · FY2014 · AI

HIV VACCINE TRIALS NETWORK LEADERSHIP GROUP

$5,093,154
Fred Hutchinson Cancer Research Center · U01 · FY2002 · AI

HIV-1 Vaccine Based on Chimp Serotypes of Adenovirus

$5,092,600
Hildegund C. J. Ertl · Wistar Institute · U19 · FY2009 · AI

CoVPN - COVID Countermeasures

$5,088,428
Ann R Falsey · University Of Rochester · UM1 · FY2020 · AI

Bioinformatics Approach to Influenza A/H1N1 Vaccine Immune Profiling

$5,081,743
Gregory A. Poland · Mayo Clinic Rochester · U01 · FY2014 · AI

IMPACTA PERU CLINICAL TRIALS UNIT

$5,080,925
Javier R Lama · Asociacion Civil Impacta Salud Y Educacn · UM1 · FY2019 · AI

B-cell Biology of Mucosal Immune Protection from SIV Challenge

$5,076,283
Eric Hunter · Emory University · U19 · FY2013 · AI

IGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - IMMUNOAFFINITY PURIFICATION OF HIV-1 ENV PROTEINS

$5,072,696
Thomas Vancott · Advanced Bioscience Laboratories, Inc. · N01 · FY2016 · AI

Development and Production of SARS-CoV2 Biologicals and Vaccines

$5,062,451
Jason Gall · National Institute Of Allergy And Infectious Diseases · ZIB · FY2023 · AI

EXTERNAL QUALITY ASSURANCE PROGRAM OVERSIGHT LABORATORY

$5,062,296
Thomas N Denny · Duke University · N01 · FY2012 · AI

INSTITUTE FOR CLINICAL AND TRANSLATIONAL RESEARCH

$5,061,727
Daniel Ernest Ford · Johns Hopkins University · UL1 · FY2007 · RR

Task 19/D21 NHP FOR SARS CORONAVIRUS VACCINE AND DRUG TESTING

$5,057,699
Lovelace Biomedical & Environmental Research Institute · N01 · FY2009 · AI

Center for Human Immunology

$5,049,028
Yasmine Belkaid · National Institute Of Allergy And Infectious Diseases · ZIC · FY2023 · AI